Resona Asset Management Co. Ltd. Has $35.46 Million Stock Position in CME Group Inc. $CME

Resona Asset Management Co. Ltd. lowered its holdings in CME Group Inc. (NASDAQ:CME) by 1.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 129,469 shares of the financial services provider’s stock after selling 2,543 shares during the period. Resona Asset Management Co. Ltd.’s holdings in CME Group were worth $35,458,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CME. Empowered Funds LLC grew its holdings in CME Group by 11.5% in the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock valued at $2,660,000 after buying an additional 1,037 shares during the last quarter. Marshall Wace LLP grew its holdings in shares of CME Group by 103.1% during the 2nd quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock worth $1,018,000 after purchasing an additional 121,707 shares in the last quarter. Federated Hermes Inc. grew its holdings in shares of CME Group by 1,325.2% during the 2nd quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock worth $6,497,000 after purchasing an additional 21,918 shares in the last quarter. Nebula Research & Development LLC acquired a new stake in shares of CME Group during the 2nd quarter worth approximately $992,000. Finally, The Manufacturers Life Insurance Company grew its holdings in shares of CME Group by 2.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock worth $79,344,000 after purchasing an additional 7,397 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Activity

In other news, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the sale, the chief executive officer owned 55,630 shares in the company, valued at approximately $16,606,111.30. The trade was a 38.62% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Martin J. Gepsman sold 300 shares of the business’s stock in a transaction on Friday, February 20th. The shares were sold at an average price of $305.90, for a total transaction of $91,770.00. Following the completion of the sale, the director owned 24,999 shares in the company, valued at $7,647,194.10. This represents a 1.19% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 42,791 shares of company stock worth $12,937,271 over the last 90 days. 0.30% of the stock is currently owned by company insiders.

CME Group Price Performance

CME Group stock opened at $305.12 on Tuesday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market capitalization of $110.56 billion, a PE ratio of 26.03, a price-to-earnings-growth ratio of 3.61 and a beta of 0.23. CME Group Inc. has a one year low of $257.17 and a one year high of $329.16. The business has a 50 day simple moving average of $297.84 and a 200 day simple moving average of $288.46.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.11 by $0.25. The firm had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business’s revenue for the quarter was up 14.5% compared to the same quarter last year. During the same period in the prior year, the company posted $2.80 earnings per share. On average, sell-side analysts forecast that CME Group Inc. will post 12.26 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Tuesday, June 9th. CME Group’s payout ratio is currently 44.37%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on CME shares. Piper Sandler lifted their price objective on CME Group from $313.00 to $329.00 and gave the stock an “overweight” rating in a report on Wednesday, April 15th. Rothschild & Co Redburn decreased their price objective on CME Group from $340.00 to $316.00 and set a “neutral” rating on the stock in a report on Monday, April 27th. Jefferies Financial Group decreased their price objective on CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a report on Thursday, April 9th. Royal Bank Of Canada lifted their price objective on CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a report on Thursday, February 5th. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a report on Thursday, April 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $305.29.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.